Cannsolve

Cannsolve (operating as The CannSolve Clinic) is a Canadian medical clinic, mental health agency, and clinical research organization specializing in personalized cannabinoid medicine and evidence-based mental health services. Founded in 2017 and based in Kamloops, British Columbia, the company provides medical cannabis clinical consultations, telemedicine services, and patient education to assist with chronic pain, mental health disorders, and recovery needs. Cannsolve is actively involved in clinical research, notably co-leading the Maverick Medical Cannabis Project, which evaluates the use of medical cannabis as an adjunctive harm-reduction therapy to combat the toxic drug and opioid overdose crisis. Through partnerships with academic institutions like Thompson Rivers University and the University of British Columbia, Cannsolve aims to integrate cannabis-based interventions into standard clinical care for complex, high-risk populations.